Cytogenetic, or molecular remission (for use in a medicare-approved demonstration project) oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic,
This is the 2011 version of HCPCS G9125 - please refer to the 2016 HCPCS code set for the latest version.
